US FDA considers reclassifying electroconvulsive therapy devices
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration, as it examines data on certain high-risk medical devices that have been on the market since 1976 before they were required to undergo a rigorous premarket approval process, is inviting specific feedback on electroconvulsive therapy devices1,2.